PRS45 - COST-EFFECTIVENESS OF BEDAQUILINE VERSUS INJECTABLE STANDARD-OF-CARE AGENTS FOR THE TREATMENT OF DRUG-RESISTANT TUBERCULOSIS (DR-TB) IN RUSSIA, INDIA, AND SOUTH AFRICA- BREAKTHROUGH INNOVATION DRIVING DOWN COST OF TREATMENT SUCCESS

Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.2439
https://www.valueinhealthjournal.com/article/S1098-3015(18)35741-3/fulltext
Section Title :
Section Order : 1793
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35741-3&doi=10.1016/j.jval.2018.09.2439
HEOR Topics :
Tags :
Regions :